CORT - Corcept Therapeutics Incorporated
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$125.33
DETAILS
HIGH:
$165.00
LOW:
$50.00
MEDIAN:
$142.50
CONSENSUS:
$125.33
UPSIDE:
9.42%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 883,001 | $76.8M | 0.0% | -298,347 | DECREASED |
| Greenblatt | 60,181 | $5.2M | 0.0% | +42,263 | INCREASED |
| Dalio | 57,602 | $5.0M | 0.0% | +19,180 | INCREASED |
| Wood | 6,000 | $521,700 | 0.0% | -50,181 | DECREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-09-15 | WILSON JAMES N | director | SELL | 400 | $110.84 | $44K |
| 2026-09-15 | WILSON JAMES N | director | SELL | 2,800 | $111.70 | $313K |
| 2026-09-14 | Lyon Joseph Douglas | officer: See Remarks | SELL | 2,188 | $114.12 | $250K |
| 2026-09-15 | WILSON JAMES N | director | SELL | 6,800 | $110.27 | $750K |
| 2026-09-14 | Lyon Joseph Douglas | officer: See Remarks | M-Exempt | 2,596 | $11.35 | $29K |
| 2026-09-14 | Lyon Joseph Douglas | officer: See Remarks | M-Exempt | 7,404 | $13.56 | $100K |
| 2026-09-14 | Lyon Joseph Douglas | officer: See Remarks | SELL | 7,812 | $113.32 | $885K |
| 2026-09-01 | Guyer William | officer: Chief Development Officer | A-Award | 164 | $113.38 | $19K |
| 2026-09-01 | Maduck Sean | officer: See Remarks | SELL | 11,730 | $113.94 | $1.3M |
| 2026-09-01 | Maduck Sean | officer: See Remarks | SELL | 10,989 | $114.71 | $1.3M |
| 2026-09-01 | Maduck Sean | officer: See Remarks | SELL | 2,281 | $115.61 | $264K |
| 2026-09-02 | Mokari Atabak | officer: Chief Financial Officer | F-InKind | 102 | $113.38 | $12K |
| 2026-09-02 | Vieira Roberto Wandenkolk | officer: President, Oncology | SELL | 23,770 | $110.70 | $2.6M |
| 2026-09-02 | Vieira Roberto Wandenkolk | officer: President, Oncology | SELL | 974 | $112.40 | $109K |
| 2026-09-02 | Vieira Roberto Wandenkolk | officer: President, Oncology | F-InKind | 102 | $113.38 | $12K |
| 2026-09-01 | Vieira Roberto Wandenkolk | officer: President, Oncology | ? | 200,000 | $21.63 | $4.3M |
| 2026-09-02 | Vieira Roberto Wandenkolk | officer: President, Oncology | SELL | 1,606 | $113.72 | $183K |
| 2026-09-01 | Vieira Roberto Wandenkolk | officer: President, Oncology | ? | 140,000 | $35.70 | $5.0M |
| 2026-09-02 | Lyon Joseph Douglas | officer: See Remarks | F-InKind | 72 | $113.38 | $8K |
| 2026-09-02 | Vieira Roberto Wandenkolk | officer: President, Oncology | SELL | 1,225 | $115.44 | $141K |
| 2026-09-01 | Robb Gary Charles | officer: Chief Business Officer | A-Award | 164 | $113.38 | $19K |
| 2026-09-01 | Maduck Sean | officer: See Remarks | M-Exempt | 25,000 | $8.27 | $207K |
| 2026-09-02 | Vieira Roberto Wandenkolk | officer: President, Oncology | SELL | 23,600 | $109.35 | $2.6M |
| 2026-09-02 | Vieira Roberto Wandenkolk | officer: President, Oncology | SELL | 5,621 | $114.58 | $644K |
| 2026-09-01 | Vieira Roberto Wandenkolk | officer: President, Oncology | ? | -- | -- | -- |